Technical analysis of Outset Medical, Inc. (OM): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features.
Price Performance
| 1 month | -27.91% |
| 3 months | -38.61% |
| Year-to-date | -16.44% |
| 1 year | -78.12% |
| 3 years | -98.33% |
52-Week Range
| 52-week High | $16.16 |
| 52-week Low | $3.00 |
| Avg Volume (90d) | 191K |
Technical Indicators
| SMA 50 | $4.18 |
| SMA 200 | $4.21 |
| Beta | 1.96 |
| 30-day Volatility (annualised) | 47.5% |
| Price vs SMA 50 | -25.9% |
| Price vs SMA 200 | -26.3% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $13.12 | |
| 2025-11 | $4.56 | -65.2% |
| 2025-12 | $3.71 | -18.6% |
| 2026-01 | $5.01 | +35.0% |
| 2026-02 | $3.49 | -30.3% |
| 2026-03 | $3.84 | +10.0% |
| 2026-04 | $4.27 | +11.2% |
| 2026-05 | $4.89 | +14.5% |
| 2026-06 | $4.32 | -11.7% |
| 2026-07 | $4.57 | +5.8% |
| 2026-08 | $3.82 | -16.4% |
| 2026-09 | $3.10 | -18.8% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-15 | | $93M |
| 2026-09-15 | $-0.08 | $66M |
| 2026-09-15 | $0.18 | $3.02B |
| 2026-09-15 | | $17M |
| 2026-09-15 | $0.88 | $2.29B |
| 2026-09-15 | | |
Price
| Price | $3.10 |
| Market Cap | $57M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.59 |
| EV / EBITDA | -2.42 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 1.08 |
| Current Ratio | 5.19 |